Assessment of psychosocial difficulties by genetic clinicians and distress in women at high risk of breast cancer: a prospective study.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
09 2022
Historique:
received: 10 11 2021
accepted: 22 03 2022
revised: 03 03 2022
pubmed: 12 4 2022
medline: 9 9 2022
entrez: 11 4 2022
Statut: ppublish

Résumé

We examined how often genetic clinicians correctly identify psychosocial difficulties in women at high breast cancer risk and explored effects of this assessment and the genetic test result on counselees' distress. A prospective observational study of counselee-clinician dyads was performed in three French, German and Spanish genetic clinics, involving 709 counselees (participation rate, 83.4%) and 31 clinicians (participation rate, 100%). Counselee-clinician agreement in perceived psychosocial difficulties was measured after the pre-test genetic consultation. Multivariate mixed linear models accounting for clinicians were tested. Predicted distress levels were assessed after the pre- (T1) and post-test result disclosure consultations (T2). Depending on the difficulty domain, clinicians adequately assessed the presence or absence of difficulties in 51% ("familial issues") to 59% ("emotions") of counselees. When counselees' and clinicians' perceptions disagreed, difficulties were generally underestimated by clinicians. Counselees' distress levels remained stable from T1 to T2, irrespective of clinicians' appraisal adequacy, and the genetic test result disclosure. Psychological referral need were found in 20-42% of counselees, more frequently observed for difficulties in the "emotions" domain. Our findings suggest that the genetic test result is a suboptimal indicator for psychological referral. Instead, clinicians should focus on emotions expressed by counselees to appraise their needs for psychological support.

Identifiants

pubmed: 35399119
doi: 10.1038/s41431-022-01096-9
pii: 10.1038/s41431-022-01096-9
pmc: PMC9437045
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1075

Informations de copyright

© 2022. The Author(s).

Références

Br J Psychiatry. 1990 Jan;156:79-83
pubmed: 2297623
Eur J Hum Genet. 2021 May;29(5):789-799
pubmed: 33437034
Psychooncology. 2014 Apr;23(4):420-7
pubmed: 24127257
Cancer. 1998 Oct 15;83(8):1640-51
pubmed: 9781960
Br J Cancer. 2013 Mar 19;108(5):1012-20
pubmed: 23462725
Clin Transl Oncol. 2015 Dec;17(12):956-61
pubmed: 26669313
Clin Genet. 2001 Nov;60(5):323-30
pubmed: 11903329
Bull Cancer. 2018 Oct;105(10):907-917
pubmed: 30268633
Psychooncology. 2005 Dec;14(12):1060-74
pubmed: 15937976
Br J Cancer. 2001 Jan;84(2):179-85
pubmed: 11161373
J Clin Oncol. 2014 Sep 20;32(27):2998-3004
pubmed: 25049325
Eur J Cancer Care (Engl). 2020 Jan;29(1):e13173
pubmed: 31571365
BMJ Open. 2019 Sep 24;9(9):e029926
pubmed: 31551380
Patient Educ Couns. 2012 Feb;86(2):239-51
pubmed: 21684708
J Genet Couns. 2014 Aug;23(4):604-17
pubmed: 24599651
Support Care Cancer. 2019 Oct;27(10):3647-3656
pubmed: 31203511
Gen Hosp Psychiatry. 2003 Jul-Aug;25(4):277-83
pubmed: 12850660
Chron Respir Dis. 2020 Jan-Dec;17:1479973120933292
pubmed: 32545998
Cancer. 2021 Apr 15;127(8):1275-1285
pubmed: 33320347
Psychooncology. 2014 Aug;23(8):862-9
pubmed: 24443031
N Engl J Med. 2021 Feb 4;384(5):428-439
pubmed: 33471991
J Genet Couns. 2008 Oct;17(5):434-51
pubmed: 18791813
Br J Cancer. 2009 Mar 24;100(6):908-12
pubmed: 19240713
BMC Psychol. 2015 Mar 11;3(1):6
pubmed: 25815195
Ann Behav Med. 2008 Oct;36(2):107-16
pubmed: 18787910
J Clin Oncol. 2011 Nov 20;29(33):4424-9
pubmed: 22010016
J Clin Oncol. 1998 Apr;16(4):1594-600
pubmed: 9552071
Eur J Hum Genet. 2019 Apr;27(4):511-524
pubmed: 30573802
Fam Med. 2005 May;37(5):360-3
pubmed: 15883903
Eur J Hum Genet. 2019 Jan;27(1):28-35
pubmed: 30206354
Patient Educ Couns. 2013 Sep;92(3):286-91
pubmed: 23746769
Breast Cancer Res Treat. 2019 May;175(1):217-228
pubmed: 30725383
Patient Educ Couns. 2021 May;104(5):933-934
pubmed: 33965008
J Genet Couns. 2021 Feb;30(1):42-50
pubmed: 33278053
Psychooncology. 2015 Sep;24(9):987-1001
pubmed: 26268799
Psychooncology. 2018 Jun;27(6):1530-1537
pubmed: 29498768
J Genet Couns. 2004 Oct;13(5):403-24
pubmed: 15604639

Auteurs

Anne Brédart (A)

Institut Curie, Supportive Care Department, Psycho-oncology Unit, 26 rue d'Ulm, 75005, Paris Cedex 05, France. anne.bredart@curie.fr.
Psychopathology and Health Process Laboratory UR4057, Psychology Institute, Paris University, 71 Avenue Edouard Vaillant, 92774, Boulogne-Billancourt, France. anne.bredart@curie.fr.

Jean-Luc Kop (JL)

Université de Lorraine, 2LPN, 3 Place Godefroy de Bouillon, 54015, Nancy Cedex, France.

Anja Tüchler (A)

Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Antoine De Pauw (A)

Institut Curie, Department of Genetics, INSERM U830, Paris University, 26 rue d'Ulm, 75005, Paris Cedex 05, France.

Alejandra Cano (A)

University Autónoma of Barcelona, Clinical and Health Psychology Department, Barcelona, Spain.

Julia Dick (J)

Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Kerstin Rhiem (K)

Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Peter Devilee (P)

Leiden University Medical Centre, Department of Human Genetics, Department of Pathology, S4-P, P.O. Box 9600, 2300 RC, Leiden, The Netherlands.

Rita Schmutzler (R)

Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

Dominique Stoppa-Lyonnet (D)

Institut Curie, Department of Genetics, INSERM U830, Paris University, 26 rue d'Ulm, 75005, Paris Cedex 05, France.

Sylvie Dolbeault (S)

Institut Curie, Supportive Care Department, Psycho-oncology Unit, 26 rue d'Ulm, 75005, Paris Cedex 05, France.
CESP, University Paris-Sud, UVSQ, INSERM, University Paris-Saclay, 16 Avenue Paul Vaillant-Couturier, 94807, Villejuif Cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH